Log in

ETR:MRKMerck KGaA News Headlines

€111.30
+1.15 (+1.04 %)
(As of 07/14/2020 06:23 AM ET)
Add
Compare
Today's Range
€109.75
Now: €111.30
€111.95
50-Day Range
€99.62
MA: €104.74
€110.55
52-Week Range
€76.22
Now: €111.30
€125.95
Volume494,252 shs
Average VolumeN/A
Market Capitalization$14.38 billion
P/E Ratio30.41
Dividend Yield2.43%
BetaN/A

Headlines

Merck KGaA (ETR MRK) News Headlines

Source:
DateHeadline
Merck says it has agreed to supply potential COVID-19 drug Rebif to EU countriesMerck says it has agreed to supply potential COVID-19 drug Rebif to EU countries
finance.yahoo.com - July 8 at 1:46 PM
Merck Announces New Analyses Showing Additional Safety and Efficacy Data for Investigational Islatravir in Combination with Doravirine in Adults with HIV-1 InfectionMerck Announces New Analyses Showing Additional Safety and Efficacy Data for Investigational Islatravir in Combination with Doravirine in Adults with HIV-1 Infection
www.businesswire.com - July 6 at 8:44 AM
Merck: New Analyses Show Additional Efficacy Data For Islatravir, Doravirine CombinationMerck: New Analyses Show Additional Efficacy Data For Islatravir, Doravirine Combination
www.nasdaq.com - July 6 at 8:44 AM
Merck and Ridgeback Bio Announce Closing of Collaboration and Licensing TransactionMerck and Ridgeback Bio Announce Closing of Collaboration and Licensing Transaction
www.businesswire.com - July 1 at 6:08 PM
FDA OKs Mercks Keytruda for highly mutating forms of colorectal cancerFDA OKs Merck's Keytruda for highly mutating forms of colorectal cancer
seekingalpha.com - June 29 at 6:06 PM
MORNING BID-Locking down?MORNING BID-Locking down?
finance.yahoo.com - June 29 at 8:05 AM
Mercks Keytruda OKd in China for 2nd-line esophageal cancerMerck's Keytruda OK'd in China for 2nd-line esophageal cancer
seekingalpha.com - June 22 at 7:44 AM
Eli Lilly Stock Is Trending But Is Merck Better?Eli Lilly Stock Is Trending But Is Merck Better?
www.forbes.com - June 22 at 7:44 AM
Merck pneumonia vaccine successful in late-stage studiesMerck pneumonia vaccine successful in late-stage studies
seekingalpha.com - June 22 at 7:44 AM
Merck: KEYTRUDA Approved For New Indication In China - Quick FactsMerck: KEYTRUDA Approved For New Indication In China - Quick Facts
www.nasdaq.com - June 22 at 7:44 AM
Merck Completes Acquisition of ThemisMerck Completes Acquisition of Themis
www.businesswire.com - June 19 at 2:38 PM
Merck completes Themis buy, coronavirus vaccine trials on tapMerck completes Themis buy, coronavirus vaccine trials on tap
seekingalpha.com - June 19 at 9:37 AM
Merck Animal Health Completes Acquisition of Quantified AgMerck Animal Health Completes Acquisition of Quantified Ag
www.businesswire.com - June 17 at 5:17 PM
Merck Prices $4.5 Bln Public Debt Offering Of Senior Unsecured Notes - Quick FactsMerck Prices $4.5 Bln Public Debt Offering Of Senior Unsecured Notes - Quick Facts
www.nasdaq.com - June 17 at 12:16 PM
Merck Prices $4.5 Billion Debt OfferingMerck Prices $4.5 Billion Debt Offering
www.businesswire.com - June 17 at 7:16 AM
Merck prices $4.5B debt offering at parMerck prices $4.5B debt offering at par
seekingalpha.com - June 17 at 7:16 AM
Pfizer and Mercks diabetes med Steglatro shows mixed results in cardiovascular outcomes studyPfizer and Merck's diabetes med Steglatro shows mixed results in cardiovascular outcomes study
seekingalpha.com - June 16 at 3:42 PM
FDA OKs new indication for Merck HPV vaccineFDA OKs new indication for Merck HPV vaccine
seekingalpha.com - June 13 at 1:02 PM
MORNING BID-Taking a breather?MORNING BID-Taking a breather?
finance.yahoo.com - June 9 at 4:27 AM
Mercks Antibiotic Recarbrio Gets FDA Nod for New IndicationMerck's Antibiotic Recarbrio Gets FDA Nod for New Indication
www.nasdaq.com - June 8 at 12:51 PM
MORNING BID-Controlling that other curveMORNING BID-Controlling that other curve
finance.yahoo.com - June 8 at 7:51 AM
FDA OKs Merck combo antibiotic for bacterial pneumoniaFDA OKs Merck combo antibiotic for bacterial pneumonia
seekingalpha.com - June 4 at 5:55 PM
MORNING BID-Sultans of stimulusMORNING BID-Sultans of stimulus
finance.yahoo.com - June 4 at 7:54 AM
Buy Merck Stock On Vaccine HopesBuy Merck Stock On Vaccine Hopes
www.nasdaq.com - May 29 at 1:37 PM
With eyes on Covid-19, Merck partners with local vaccine patch makerWith eyes on Covid-19, Merck partners with local vaccine patch maker
www.bizjournals.com - May 28 at 12:09 PM
Merck and Twitch Join Forces on World Multiple Sclerosis Day to Connect People Living With MSMerck and Twitch Join Forces on World Multiple Sclerosis Day to Connect People Living With MS
finance.yahoo.com - May 28 at 7:09 AM
Merck makes big push into Covid-19 arena with three new dealsMerck makes big push into Covid-19 arena with three new deals
www.bizjournals.com - May 27 at 3:44 PM
MORNING BID-Stocks rally soldiers on as Hong Kong protests flare upMORNING BID-Stocks rally soldiers on as Hong Kong protests flare up
finance.yahoo.com - May 27 at 5:43 AM
Merck Inks Deals, Joins Coronavirus Vaccine RaceMerck Inks Deals, Joins Coronavirus Vaccine Race
www.nasdaq.com - May 26 at 12:35 PM
Merck Leaps Into the Covid-19 Find-a-Cure ArenaMerck Leaps Into the Covid-19 Find-a-Cure Arena
www.thestreet.com - May 26 at 12:35 PM
COVID-19 vaccine timeframe very aggressive - Merck CEOCOVID-19 vaccine timeframe 'very aggressive' - Merck CEO
seekingalpha.com - May 26 at 12:35 PM
Merck to Announce Multiple Scientific Efforts to Combat COVID-19Merck to Announce Multiple Scientific Efforts to Combat COVID-19
www.businesswire.com - May 26 at 7:34 AM
Merck gets busy on the COVID-19 frontMerck gets busy on the COVID-19 front
seekingalpha.com - May 26 at 7:34 AM
Merck to Acquire ThemisMerck to Acquire Themis
www.businesswire.com - May 26 at 7:34 AM
Merck jumps into COVID-19 arena with three initiativesMerck jumps into COVID-19 arena with three initiatives
seekingalpha.com - May 26 at 7:34 AM
Surface Oncology collaborates with Merck for immuno-oncology study; shares up 35%Surface Oncology collaborates with Merck for immuno-oncology study; shares up 35%
seekingalpha.com - May 20 at 8:18 AM
Mercks (MRK) Keytruda Successful in Several Cancer StudiesMerck's (MRK) Keytruda Successful in Several Cancer Studies
www.nasdaq.com - May 15 at 5:42 PM
MORNING BID-Friday stocks bounce to cap week of gloomMORNING BID-Friday stocks bounce to cap week of gloom
finance.yahoo.com - May 15 at 7:41 AM
Merck’s Novel HIF-2α Inhibitor Showed an Objective Response Rate of Nearly 30% in Patients with von Hippel-Lindau (VHL) Disease-Associated Clear Cell Renal Cell CarcinomaMerck’s Novel HIF-2α Inhibitor Showed an Objective Response Rate of Nearly 30% in Patients with von Hippel-Lindau (VHL) Disease-Associated Clear Cell Renal Cell Carcinoma
www.businesswire.com - May 13 at 7:50 PM
Breakthrough Innovation in Cancer Care From Merck Pipeline to Be Presented at ASCO 2020Breakthrough Innovation in Cancer Care From Merck Pipeline to Be Presented at ASCO 2020
finance.yahoo.com - May 13 at 7:50 PM
/C O R R E C T I O N -- EMD Serono//C O R R E C T I O N -- EMD Serono/
finance.yahoo.com - May 13 at 7:50 PM
Merck Commits Additional $10 Million to COVID-19 Relief Efforts to Help Disparately Impacted Patients and CommunitiesMerck Commits Additional $10 Million to COVID-19 Relief Efforts to Help Disparately Impacted Patients and Communities
www.businesswire.com - May 5 at 10:07 AM
MORNING BID-Lockdown easing optimism boosts market moodMORNING BID-Lockdown easing optimism boosts market mood
finance.yahoo.com - May 5 at 3:58 AM
Did Merck Just Receive a Gift From the FDA?Did Merck Just Receive a Gift From the FDA?
www.fool.com - May 1 at 11:55 AM
Pfizer aims for 10-20 mln doses of coronavirus vaccine by end-2020 depending on trialsPfizer aims for 10-20 mln doses of coronavirus vaccine by end-2020 depending on trials
finance.yahoo.com - April 30 at 8:30 PM
Stock Alert: Merck Down More Than 1%Stock Alert: Merck Down More Than 1%
www.nasdaq.com - April 30 at 3:30 PM
Data From Merck at ASCO 2020 to Showcase Significant Clinical Advances in Cancer CareData From Merck at ASCO 2020 to Showcase Significant Clinical Advances in Cancer Care
finance.yahoo.com - April 30 at 3:30 PM
Merck Analysts Focus On Fundamentals, Keytruda Strength Following Guidance CutMerck Analysts Focus On Fundamentals, Keytruda Strength Following Guidance Cut
www.benzinga.com - April 29 at 11:33 AM
Merck EPS beats by $0.16, beats on revenueMerck EPS beats by $0.16, beats on revenue
seekingalpha.com - April 28 at 4:04 PM
Merck Earnings: Why MRK Stock Is 3% Lower Despite Q1 BeatsMerck Earnings: Why MRK Stock Is 3% Lower Despite Q1 Beats
investorplace.com - April 28 at 4:04 PM
This page was last updated on 7/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.